"Novel Strategy Unveiled for Combatting Bacterial Infections"
Researchers at Icahn Mount Sinai have discovered a new approach to combat bacterial infections by harnessing the self-killing activity of bacteria through the cyclic oligonucleotide-based antiphage signaling system (CBASS). By activating the bacterial defense mechanism, they found a way to control infections and potentially manage antibiotic resistance. The team's findings, published in Nature Structural & Molecular Biology, could lead to innovative tools for fighting superbugs and staying ahead of evolving drug resistance.
